Clival chordomas and chondrosarcomas in Denmark-Outcomes in 33 patients following the national centralization of treatment in 2010.

Autor: Skotting MB; Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark. Mbskotting@gmail.com., Poulsgaard L; Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark., Springborg JB; Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark., Sundbye F; Department of Oncology, Hospital of Herlev and Gentofte, Herlev, Denmark., Engelmann BE; Department of Oncology, Hospital of Herlev and Gentofte, Herlev, Denmark.; Danish Particle Center, Aarhus University Hospital, Aarhus, Denmark., Scheie D; Department of Diagnostic Pathology, Copenhagen University Hospital, Copenhagen, Denmark., Ciochon UM; Department of Diagnostic Radiology, Copenhagen University Hospital, Copenhagen, Denmark., Guldberg F; Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark., Fugleholm K; Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.
Jazyk: angličtina
Zdroj: Acta neurochirurgica [Acta Neurochir (Wien)] 2024 Aug 29; Vol. 166 (1), pp. 354. Date of Electronic Publication: 2024 Aug 29.
DOI: 10.1007/s00701-024-06241-5
Abstrakt: Purpose: This 13-year consecutive case series aims to provide a comprehensive overview of all patients operated for clival chordomas and clival chondrosarcomas in Denmark since the centralization of treatment in 2010, comparing outcomes to international series.
Methods: This was a retrospective review of 33 patients with clival tumors, comprising 22 chordomas and 11 chondrosarcomas, who were treated at Copenhagen University Hospital between years 2010 and 2023. Data were collected from digital patient records and pathology reports.
Results: The symptoms leading to diagnosis primarily included double vision, headaches, and dizziness. In general, patients were in good health, with a mean Charlson Comorbidity Index score of 1.6. The complication rate of the index surgery was 51.5%. Adjuvant radiotherapy was applied in 51.5% of the cases. In patients with clival chordomas, the mean age was 51.1 years, ranging from 16 to 83 years. At the time of diagnosis, the mean tumor volume was 20.9 cm 3 and the five-year overall survival rates were 79.1% (95% confidence interval (CI): 62.4-100). In patients with chondrosarcomas, the mean age was 48.2 years, ranging from 15 to 76 years. At the time of diagnosis, the mean tumor volume was 22.3 cm 3 and the five-year overall survival 90% (95% CI: 73.2-100).
Conclusion: The centralized treatment of clival tumors in Denmark demonstrates incidence, survival, and complication rates comparable to those found in other international series. Given the variations in treatment strategies, tumor localizations across series, and small sample sizes, the further analysis of larger compiled multicenter datasets for clival tumors could provide more solid evidence regarding the management of these rare tumors.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: